Canadian Scientists Engineer Bacteria to Target Cancer

Canadian scientists are pioneering a groundbreaking approach to cancer treatment by engineering bacteria that can selectively target and destroy cancer cells. This innovative method involves modifying specific strains of bacteria to enhance their ability to identify and infiltrate tumors. The engineered bacteria are designed to thrive in the unique environment of cancerous tissues, allowing them to deliver therapeutic agents directly to the tumor site.

The research focuses on the bacteria’s natural capabilities to recognize and consume cancer cells while minimizing damage to healthy tissue. This targeted therapy aims to reduce the side effects commonly associated with traditional cancer treatments like chemotherapy and radiation.

Initial studies have shown promising results in preclinical models, leading to hopes that this approach could be translated into effective treatments for patients in the near future. The scientists are also exploring the potential for these engineered bacteria to be used in combination with existing therapies to enhance their effectiveness.

Source: news.google.com